Pinealon (Glu-Asp-Arg, also known as EDR) is a synthetic tripeptide bioregulator developed at the Saint Petersburg Institute of Bioregulation and Gerontology by Professor Vladimir Khavinson. It specifically targets the central nervous system and pineal gland. Research has shown that Pinealon can modulate melatonin synthesis, enhance antioxidant defenses in neural tissue, and protect neurons from age-related damage.
Key Data
Mechanism of Action
Pinealon modulates gene expression in neurons and pinealocytes by penetrating cell membranes and interacting with DNA regulatory regions. It promotes melatonin synthesis in the pineal gland, enhances antioxidant defense in neural tissue, and supports neurotransmitter balance.
Reported Benefits
All information is presented for Research Use Only (RUO). Not medical advice.